Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nxstage Medical Inc (NXTM)

Nxstage Medical Inc (NXTM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,000,400
  • Shares Outstanding, K 66,685
  • Annual Sales, $ 393,940 K
  • Annual Income, $ -14,470 K
  • 60-Month Beta 0.25
  • Price/Sales 4.70
  • Price/Cash Flow N/A
  • Price/Book 8.71
Trade NXTM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/22/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.04
  • Low Estimate 0.02
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.00 +7.14%
on 01/25/19
30.00 unch
on 02/21/19
+1.50 (+5.26%)
since 01/18/19
3-Month
26.00 +15.38%
on 11/30/18
30.00 unch
on 02/21/19
+0.93 (+3.20%)
since 11/21/18
52-Week
23.17 +29.48%
on 03/01/18
30.00 unch
on 02/21/19
+5.62 (+23.05%)
since 02/21/18

Most Recent Stories

More News
Global Home Dialysis Equipment Market Analysis

According to a new market research report published by Global Market Estimates, the Home Dialysis Equipment Market is projected to grow at a CAGR of 5.2 percent from 2021 to 2026. NxStage Medical Inc.,...

BAX : 86.52 (-0.05%)
NXTM : 30.00 (+0.03%)
Global Dialysis Market Analysis and Industry Forecast to 2030: Hemodialysis and Peritoneal Dialysis & Equipment, Consumables, Dialysis Drugs and Services

, /PRNewswire/ -- The report has been added to offering.

AHKSF : 11.4700 (unch)
DVA : 110.78 (-2.06%)
NXTM : 30.00 (+0.03%)
Shares of NXTM Up 20.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 41 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)
Uptrend Call Working As Nxstage Medical Stock Rises 20.0% (NXTM)

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 40 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)
Chronic Diseases Tend To Lead To Kidney Failure, Thus An Increase Drives The Dialysis Devices And Equipment Market

(Dialysis Devices And Equipment Companies Included: Fresenius Medical Care AG & Co. KGaA, Baxter International, Nikkiso Co. Ltd, DaVita Inc., B. Braun Avitum AG, NxStage Medical, Asahi Kasei Corporation,...

AHKSF : 11.4700 (unch)
BAX : 86.52 (-0.05%)
DVA : 110.78 (-2.06%)
MDT : 126.13 (+0.17%)
NXTM : 30.00 (+0.03%)
TFX : 431.79 (-0.18%)
Nxstage Medical Up 20.0% Since SmarTrend Uptrend Call (NXTM)

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 40 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)
Nxstage Medical Up 20.0% Since SmarTrend Uptrend Call (NXTM)

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 40 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)
20.0% Return Seen to Date on SmarTrend Nxstage Medical Call (NXTM)

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 39 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)
The global kidney cancer therapeutics and diagnostics market is projected to register a CAGR of 5.52% during the forecast period, 2019-2028

, /PRNewswire/ --The global kidney cancer therapeutics and diagnostics market is projected to register a CAGR of 5.52% during the forecast period, 2019-2028. The factors propelling the growth of the market...

ABT : 124.53 (+0.14%)
AMGN : 255.97 (+0.10%)
BAYRY : 16.5900 (+2.28%)
MRK : 77.66 (+0.25%)
MKKGY : 35.5200 (-0.67%)
NVS : 88.38 (+0.41%)
NXTM : 30.00 (+0.03%)
PFE : 38.93 (+0.93%)
Shares of NXTM Up 20.0% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Nxstage Medical (NASDAQ:NXTM) on June 28th, 2017 at $25.01. In approximately 39 months, Nxstage Medical has returned 19.98% as of today's recent price of $30.00.

NXTM : 30.00 (+0.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 30.01
1st Resistance Point 30.01
Last Price 30.00
1st Support Level 29.99
2nd Support Level 29.97
3rd Support Level N/A

See More

52-Week High 30.00
Last Price 30.00
Fibonacci 61.8% 27.39
Fibonacci 50% 26.58
Fibonacci 38.2% 25.78
52-Week Low 23.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar